Commercial disclosure
CoreAge Rx receives the first commercial position in The Next Regular. This publication belongs to its promotional publishing network; the placement is not an independent selection of the best product for people over fifty.
Where the placement appears
Product listings and the comparison put CoreAge first commercially. Articles include a short labeled placement after their two introduction paragraphs, with links to the local Full House review, its seller offer and this disclosure. The footer carries the publication’s full affiliation notice. A review’s authored discussion of that relationship remains part of its text.
What the offer link carries
The Full House offer link includes four attribution values: this site’s domain, a referral medium, the Full House campaign and the article’s route. Those values describe the link’s publishing context; they are not answers to health questions. The external offer link is marked sponsored and nofollow. The seller controls the destination and its own information practices.
A displayed offer is not a tested order
Plan totals, stated supply units and monthly-equivalent displays are reported together. Optional refills, shipping conditions and the unresolved relationship between return deadlines remain separate parts of that record. No checkout, selected renewal, delivery or refund has been tested for these reviews, and a supply commitment cannot determine a person’s clinical follow-up.
Commercial order does not resolve a care question
CoreAge’s position does not establish greater effectiveness, safety, allergy suitability or medicine compatibility. Competitor entries are descriptions of particular records, not equivalent substitutions. Questions about a selected transaction belong with its seller; swallowing, fluid restrictions, symptoms and treatment decisions require the appropriate care professional. An ordinary commercial-support channel is not emergency care.